Steven MacLennan

Medicine & Life Sciences

1. Systematic Reviews 100%
2. Prostatic Neoplasms 80%
3. Urology 77%
4. Guidelines 48%
5. Urinary Bladder Neoplasms 42%
6. Practice Guidelines 39%
7. Meta-Analysis 29%
8. Randomized Controlled Trials 22%
9. Patient Participation 17%
10. Consensus 17%
11. Lithotripsy 16%
12. Lymph Node Excision 16%
13. Percutaneous Nephrolithotomy 15%
14. Guideline Adherence 14%
15. Kidney Neoplasms 14%
16. Watchful Waiting 13%
17. Big Data 13%
18. Biopsy 13%
19. Intravesical Administration 12%
20. Therapeutics 12%
21. Patient Reported Outcome Measures 12%
22. Nephrectomy 11%
23. Penile Neoplasms 11%
24. Spermatic Cord Torsion 11%
25. Orchiopexy 11%
26. Nephroureterectomy 10%
27. Urolithiasis 10%
28. Delivery of Health Care 10%
29. Recurrence 10%
30. Medical Oncology 9%
31. Quality of Life 9%
32. Cystectomy 8%
33. Castration 8%
34. Positron Emission Tomography Computed Tomography 8%
35. Prostate-Specific Antigen 8%
36. Prostate 8%
37. Kidney Calculi 7%
38. Kidney 7%
39. Androgens 7%
40. Education 7%
41. Observational Studies 7%
42. Uncertainty 6%
43. Renal Cell Carcinoma 6%
44. Stress Urinary Incontinence 6%
45. Length of Stay 5%
46. Cystostomy 5%
47. Stakeholder Participation 5%
48. Urinary Bladder 5%
49. Adrenalectomy 5%